Insiders Updates An Analysis of Pliant Therapeutics Inc (PLRX)’s Potential Price Growth Pliant Therapeutics Inc’s recently made public that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million
Stock Earnings Pliant Therapeutics Inc [PLRX] Investment Appeal on the Rise Pliant Therapeutics Inc’s recently made public that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million
Insiders Updates Positive sentiment towards PLRX reflected by a fall of -49.73% in short interest The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Analysts review Pliant Therapeutics Inc’s rating Pliant Therapeutics Inc’s recent filing unveils that its President and CEO Coulie Bernard unloaded Company’s shares for reported $0.59 million